Published by
@ShahidNShah
@ShahidNShah
March 26 to March 28, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The 5th Glioblastoma Drug Development Summit brings together large pharma, biotech, neuro-oncologists, academic experts, and investors with a shared mission to overcome barriers in glioblastoma (GBM) treatment. The summit explores innovative strategies for crossing the blood-brain barrier, optimizing clinical trial designs, and navigating regulatory pathways for combination therapies. With advances in therapeutic modalities and emerging drug targets, the potential for GBM treatment is greater than ever. This collaborative event, featuring industry leaders, pioneering biotechs, academics, and investors, aims to elevate standards, achieve positive clinical outcomes, and unite the community in the fight against GBM and CNS tumors. The summit takes place from March 26 to 28, 2024.
Read on glioblastoma-drugdevelopment.com
Continue reading at glioblastoma-drugdevelopment.com
March 27 to March 28, 2024
Hotel NH Sants Barcelona, Numancia, 74, 08029 Barcelona, Spain
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am